EDN1 and Parkinson disease: The neurodegenerative and neuroinflammatory changes observed in the CIP model, along with PAR1 upregulation and ET1 increase, harmonizes with the work of Ishida et al. [21] who found increased PAR1 expression in postmortem specimens of patients with parkinsonism.